ELM-1 is an ongoing, open-label, multicenter Phase 1 trial to investigate the safety and tolerability of odronextamab in patients with CD20+ B-cell malignancies previously treated with CD20-directed ...
The major ocean carriers have struggled for years to conduct business in Syria while complying with international sanctions.
New tariffs by the Trump administration on products from China, Canada and Mexico will hit companies and consumers with increased costs, experts said.
TK As the first made-in-Canada production EVs start rolling off the line at the Stellantis plant in Windsor, Ont., we take an ...